https://allsci.com/news/clinical-trials/hiv-latency-reversing-agent-actg-tests/ AllScien 2026-08-24T11:50:43.597976Z ACTG repurposes alendronate in bid to shrink latent HIV reservoir https://allsci.com/news/clinical-trials/moderna-rsv-hmpv-vaccine-launches-phase-study-of/ AllScien 2026-08-24T11:37:26.489993Z Moderna takes RSV/hMPV vaccine back to clinic after earlier pediatric hold https://allsci.com/news/regulatory/orm-1153-fda-clearance-aml-orum-therapeutics-wins/ AllScien 2026-08-24T11:22:26.939045Z Orum moving CD123-targeted DAC into first-in-human testing against AML https://allsci.com/news/regulatory/apitegromab-fda-approval-scholar-rock-advances/ AllScien 2026-08-24T11:14:40.673669Z Scholar Rock withdraws EU apitegromab filing over manufacturing site issue https://allsci.com/news/licensing-and-partnerships/genentech-hanmi-obesity-drug-deal-pays-usd-190m/ AllScien 2026-08-24T11:11:57.891829Z Roche continues obesity shopping with USD 2.3b deal for Hanmi’s UCN2 analog https://allsci.com/news/licensing-and-partnerships/abt-301-solid-tumors-anbogen-partners-with/ AllScien 2026-08-24T11:06:35.061158Z Anbogen taps University of Tokyo to explore new indications for ABT-301 https://allsci.com/news/grants/mitral-valve-prolapse-research-university-of/ AllScien 2026-08-24T10:52:43.286058Z Rochester Uni backed by NIH to explore PKD3 as cardiac therapeutic target https://allsci.com/news/licensing-and-partnerships/rna-editing-therapeutics-rznomics-relocates-to/ AllScien 2026-08-24T10:50:49.638651Z Lilly's RNA partner Rznomics joins Lilly Gateway Labs